Response rates of taxane rechallenge in metastatic breast cancer patients, previously treated with adjuvant taxanes.

被引：1
|
作者：
Oguz, Arzu
Babacan, Taner
Dizdar, Omer
Kucukoztas, Nadire
Rahatli, Samed
Keskin, Gul Sema Yildiran
Altundag, Ozden
Altundag, Kadri
机构：
[1] Baskent Univ, Dept Med Oncol, TR-06490 Ankara, Turkey
[2] Hacettepe Univ, Inst Oncol, Dept Med Oncol, Ankara, Turkey
[3] Baskent Univ Hosp, Ankara, Turkey
[4] Baskent Univ, Sch Med, TR-06490 Ankara, Turkey
[5] Baskent Univ, Fac Med, TR-06490 Ankara, Turkey
[6] Hacettepe Univ, Inst Canc, Dept Med Oncol, Ankara, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1073
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prescription patterns for metastatic breast cancer patients previously treated with anthracycline and taxane: An assessment in a United States managed care database
    Harris, L. A.
    Yu, Y.
    Donato, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Phase I study of ixabepilone in combination with capecitabine in Japanese patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
    Watanabe, J.
    Horiguchi, J.
    Masuda, N.
    Aogi, K.
    Sato, R.
    Tokudome, T.
    Peck, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] RESPONSE TO CHEMOTHERAPY OR CHEMOENDOCRINE THERAPY IN PATIENTS WITH ADVANCED BREAST-CANCER PREVIOUSLY TREATED WITH ADJUVANT CHEMOTHERAPY
    KARDINAL, CG
    PERRY, MC
    KORZUN, AH
    WOOD, W
    BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 185 - 185
  • [44] RESPONSE TO SECONDARY THERAPY IN PATIENTS WITH ADENOCARCINOMA OF THE BREAST PREVIOUSLY TREATED WITH ADJUVANT CHEMOTHERAPY
    BITRAN, JD
    DESSER, RK
    SHAPIRO, CM
    MICHEL, A
    KOZLOFF, MF
    BILLINGS, AA
    RECENT, W
    CANCER, 1983, 51 (03) : 381 - 384
  • [45] Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines
    Vassilomanolakis, M
    Koumakis, G
    Barbounis, V
    Demiri, M
    Pateras, H
    Efremidis, AP
    ANNALS OF ONCOLOGY, 2000, 11 (09) : 1155 - 1160
  • [46] UFT plus Oral Folinic Acid with Alternating Oral and Intravenous Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes
    Coskun, Ugur
    Kaya, Ali Osman
    Alkis, Necati
    Buyukberber, Sueleyman
    Alici, Sueleyman
    Celenkoglu, Goekhan
    Uncu, Dogan
    Ozkan, Metin
    Sevinc, Alper
    Benekli, Mustafa
    ONKOLOGIE, 2009, 32 (10): : 562 - 566
  • [47] A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Sunela, Kaisa
    Lehtinen, Ilari
    Joensuu, Heikki
    Sjostrom-Mattson, Johanna
    CLINICAL BREAST CANCER, 2006, 7 (05) : 401 - 405
  • [48] SAFETY AND EFFICACY OF VINORELBINE PLUS LOW-DOSE METRONOMIC CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINES AND TAXANES
    Kudo, S.
    Makino, T.
    Hasunuma, A.
    Ahiko, Y.
    ANNALS OF ONCOLOGY, 2014, 25
  • [49] Cisplatin-vinorelbine as first line chemotherapy in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes: Results of a retrospective analysis
    Raafat, J.
    Mourad, C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S182 - S182
  • [50] Gemcitabine plus cisplatin in patients with locally advanced or metastatic breast cancer (MBC) who failed prior anthracycline therapy ± taxanes.
    El Khodary, A
    Gouda, Y
    Al Noweim, S
    Kohail, H
    Gaafar, R
    Zawahry, H
    Wareth, AA
    Mansour, O
    Shehata, S
    Hamid, TA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 69S - 69S
12345